These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8570867)

  • 1. Concentrating capacity in ifosfamide-induced severe renal dysfunction.
    Rossi R; Gödde A; Kleinebrand A; Rath B; Jürgens H
    Ren Fail; 1995 Sep; 17(5):551-7. PubMed ID: 8570867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fanconi's syndrome and nephrogenic diabetes insipidus in an adult treated with ifosfamide.
    Ingemi AI; Bota VM; Peguero A; Charpentier M
    Pharmacotherapy; 2012 Jan; 32(1):e12-6. PubMed ID: 22392832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients.
    Rossi R; Pleyer J; Schäfers P; Kuhn N; Kleta R; Deufel T; Jürgens H
    Med Pediatr Oncol; 1999 Mar; 32(3):177-82. PubMed ID: 10064184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients.
    Rossi R; Gödde A; Kleinebrand A; Riepenhausen M; Boos J; Ritter J; Jürgens H
    J Clin Oncol; 1994 Jan; 12(1):159-65. PubMed ID: 8270973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fanconi's syndrome due to ifosfamide.
    Beckwith C; Flaharty KK; Cheung AK; Beatty PG
    Bone Marrow Transplant; 1993 Jan; 11(1):71-3. PubMed ID: 8431714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases.
    Rossi R; Helmchen U; Schellong G
    Eur J Pediatr; 1992 May; 151(5):384-7. PubMed ID: 1396897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide-induced subclinical nephrotoxicity and its potentiation by cisplatinum.
    Rossi R; Danzebrink S; Hillebrand D; Linnenbürger K; Ullrich K; Jürgens H
    Med Pediatr Oncol; 1994; 22(1):27-32. PubMed ID: 8232077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ifosfamide-induced nephrotoxicity].
    Rossi R; Rath B; Ullrich K; Ehrich JH
    Monatsschr Kinderheilkd; 1993 Jul; 141(7):594-601. PubMed ID: 8413339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis.
    Rossi RM; Kist C; Wurster U; Külpmann WR; Ehrich JH
    Pediatr Nephrol; 1994 Apr; 8(2):151-6. PubMed ID: 8018491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide, Fanconi's syndrome, and rickets.
    Pratt CB; Meyer WH; Jenkins JJ; Avery L; McKay CP; Wyatt RJ; Hancock ML
    J Clin Oncol; 1991 Aug; 9(8):1495-9. PubMed ID: 1649270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults.
    Ho PT; Zimmerman K; Wexler LH; Blaney S; Jarosinski P; Weaver-McClure L; Izraeli S; Balis FM
    Cancer; 1995 Dec; 76(12):2557-64. PubMed ID: 8625085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide-induced Fanconi syndrome with diabetes insipidus.
    Leem AY; Kim HS; Yoo BW; Kang BD; Kim MH; Rha SY; Kim HS
    Korean J Intern Med; 2014 Mar; 29(2):246-9. PubMed ID: 24648810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial and complete de Toni-Debré-Fanconi syndrome after ifosfamide chemotherapy of childhood malignancy.
    Rossi R; Ehrich JH
    Eur J Clin Pharmacol; 1993; 44 Suppl 1():S43-5. PubMed ID: 8486147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of ifosfamide-induced acute kidney injury, Fanconi syndrome, and nephrogenic diabetes insipidus.
    Hoang S; Pujar T; Bellorin-Font E; Edwards JC; Miyata KN
    CEN Case Rep; 2024 Jun; 13(3):194-198. PubMed ID: 37897631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide-induced Fanconi's syndrome with growth failure in a 2-year-old child.
    De Schepper J; Stevens G; Verboven M; Baeta C; Otten J
    Am J Pediatr Hematol Oncol; 1991; 13(1):39-41. PubMed ID: 2029077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity of ifosfamide--moving towards understanding the molecular mechanisms.
    Rossi R
    Nephrol Dial Transplant; 1997 Jun; 12(6):1091-2. PubMed ID: 9198030
    [No Abstract]   [Full Text] [Related]  

  • 17. A systematic review of the accuracy and utility of early markers of Ifosfamide-induced proximal tubulopathy in survivors of childhood cancers.
    Phillips RS; Tyerman K; Al-Kassim MI; Picton S
    Pediatr Hematol Oncol; 2008 Mar; 25(2):107-13. PubMed ID: 18363176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report.
    Suarez A; McDowell H; Niaudet P; Comoy E; Flamant F
    J Clin Oncol; 1991 Dec; 9(12):2177-82. PubMed ID: 1720453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide-induced renal Fanconi syndrome with associated nephrogenic diabetes insipidus in an adult patient.
    Negro A; Regolisti G; Perazzoli F; Davoli S; Sani C; Rossi E
    Nephrol Dial Transplant; 1998 Jun; 13(6):1547-9. PubMed ID: 9641191
    [No Abstract]   [Full Text] [Related]  

  • 20. Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats.
    Nissim I; Weinberg JM
    Kidney Int; 1996 Mar; 49(3):684-95. PubMed ID: 8648909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.